[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 722550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 593605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 433620, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.57, "open": 6.6735, "dayLow": 6.0, "dayHigh": 7.0862, "regularMarketPreviousClose": 6.57, "regularMarketOpen": 6.6735, "regularMarketDayLow": 6.0, "regularMarketDayHigh": 7.0862, "payoutRatio": 0.0, "beta": 1.609, "forwardPE": -5.041322, "volume": 31880, "regularMarketVolume": 31880, "averageVolume": 230277, "averageVolume10days": 44120, "averageDailyVolume10Day": 44120, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3587818, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 54.95, "fiftyDayAverage": 8.71596, "twoHundredDayAverage": 17.610664, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 114440512, "profitMargins": 0.0, "floatShares": 19128985, "sharesOutstanding": 588167, "sharesShort": 12505, "sharesShortPriorMonth": 24821, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.021300001, "heldPercentInsiders": 0.07077, "heldPercentInstitutions": 0.07598, "shortRatio": 0.04, "shortPercentOfFloat": 0.0947, "impliedSharesOutstanding": 20585800, "bookValue": 36.003, "priceToBook": 0.16943033, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -8962472, "trailingEps": -66.85, "forwardEps": -1.21, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -12.138, "52WeekChange": -0.76605946, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 6.1, "targetHighPrice": 350.00034, "targetLowPrice": 50.40005, "targetMeanPrice": 156.80016, "targetMedianPrice": 70.00007, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 14056878, "totalCashPerShare": 0.683, "ebitda": -9428465, "totalDebt": 2923733, "quickRatio": 3.362, "currentRatio": 3.57, "debtToEquity": 31.764, "returnOnAssets": -0.42723, "returnOnEquity": -1.20555, "freeCashflow": -4275041, "operatingCashflow": -7857309, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "epsTrailingTwelveMonths": -66.85, "epsForward": -1.21, "epsCurrentYear": -17.50002, "priceEpsCurrentYear": -0.34857103, "fiftyDayAverageChange": -2.6159596, "fiftyDayAverageChangePercent": -0.30013445, "twoHundredDayAverageChange": -11.510664, "twoHundredDayAverageChangePercent": -0.65361893, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-05-02", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": 0.0, "postMarketPrice": 6.1, "postMarketChange": 0.0, "regularMarketChange": -0.47000027, "regularMarketDayRange": "6.0 - 7.0862", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 230277, "fiftyTwoWeekLowChange": 1.0899997, "fiftyTwoWeekLowChangePercent": 0.21756479, "fiftyTwoWeekRange": "5.01 - 54.95", "fiftyTwoWeekHighChange": -48.850002, "fiftyTwoWeekHighChangePercent": -0.88899004, "fiftyTwoWeekChangePercent": -76.60595, "dividendDate": 1571788800, "earningsTimestamp": 1741865400, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "corporateActions": [], "postMarketTime": 1746228587, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.1537333, "regularMarketPrice": 6.1, "marketState": "CLOSED", "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]